PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL
Version 2 2024-06-19, 00:50Version 2 2024-06-19, 00:50
Version 1 2021-01-11, 15:54Version 1 2021-01-11, 15:54
conference contribution
posted on 2024-06-19, 00:50authored byEric Thompson, Daniel Landi, Eric Lipp, Bea Balajonda, James Herndon, Evan Buckley, Charlene Flahiff, Denise Jaggers, Kristin Schroeder, Dina Randazzo, Annick Desjardins, Maggie Johnson, Katherine Peters, Mustafa Khasraw, Michael Malinzak, Duane Mitchell, David Ashley, John Sampson
PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL